MetaCap

Who Owns Amylyx Pharmaceuticals Stock?

NASDAQ: AMLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

26.02-0.18 (-0.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
97.87%
Institutional holders
307
  • Institutions 93.1%
  • Insiders 6.9%
  • Public and other 0.0%

Who owns Amylyx Pharmaceuticals stock?

Institutional investors own about 97.9% of Amylyx Pharmaceuticals's shares, spread across 307 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 6.85% of AMLX.

The largest institutional holders are FMR, LLC (15.51%), Blackrock Inc. (8.06%) and Perceptive Advisors Llc (6.48%). Together, the top 10 institutions control 56.7% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their AMLX positions and 0 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of AMLX

Amylyx Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
FMR, LLC19.95M15.51%+19.2%
Blackrock Inc.10.37M8.06%+17.5%
Perceptive Advisors Llc8.33M6.48%+0.6%
TCG Crossover Management, LLC6.24M4.86%0.0%
Commodore Capital Lp5.65M4.39%0.0%
Jupiter Topco LLC5.24M4.07%+100.0%
Vanguard Capital Management LLC5.08M3.95%+20.2%
Saturn V Capital Management LP4.62M3.60%+6.3%
Franklin Templeton, Inc.3.93M3.06%+33.3%
JPMORGAN CHASE & CO3.43M2.67%+84.3%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of AMLX

Amylyx Pharmaceuticals top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.15M2.45%
iShares Trust-iShares Russell 2000 ETF2.69M2.10%
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund2.43M1.89%
Fidelity Securities Fund-Fidelity Small Cap Growth Fund2.12M1.65%
Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total 1.70M1.32%
Fidelity Select Portfolios-Select Biotechnology Portfolio1.60M1.25%
Fidelity Select Portfolios-Select Health Care Portfolio1.60M1.24%
Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund1.48M1.15%
MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund1.32M1.03%
Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund1.18M0.92%

Frequently asked questions

Who is the largest shareholder of Amylyx Pharmaceuticals?

FMR, LLC is the largest institutional shareholder of AMLX, owning 15.51% of shares outstanding (19.95M shares) as of its latest 13F filing.

What percentage of Amylyx Pharmaceuticals is owned by institutions?

Institutions own about 97.9% of AMLX shares and 105.1% of the public float.

How much of Amylyx Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 6.85% of AMLX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related